Analysis of primary prevention services for cardiovascular disease in Australia's community pharmacies

Australian and New Zealand Journal of Public Health

Volumn 31, Issue 6, 2007, Pages 516-519

  Joyce, Andrew ^a   Berbatis, Constantine G ^a   Sunderland, V Bruce ^a   Dhaliwal, Satvinder S ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Cardiovascular diseases; Pharmacy; Preventive health services

Indexed keywords

ADULT; ANTHROPOMETRY; ARTICLE; AUSTRALIA; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MASS SCREENING; NICOTINE REPLACEMENT THERAPY; PATIENT COUNSELING; PHARMACY; PREDICTION; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIMARY PREVENTION; QUESTIONNAIRE;

ADULT; AGE FACTORS; AUSTRALIA; CARDIOVASCULAR DISEASES; DATABASES AS TOPIC; DELIVERY OF HEALTH CARE; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PHARMACIES; PRIMARY PREVENTION; QUESTIONNAIRES;

EID: 38349014147     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2007.00135.x     Document Type: Article

References (17)

1. Australian Institute of Health and Welfare. Australia's Health 2006. Canberra (AUST): AIHW; 2006. Catalogue No.: AUS 73.
2. Hurley SF, Scollo MM, Younie SJ, English DR, Swanson MG. The potential for tobacco control to reduce PBS costs for smoking-related cardiovascular disease. Med J Aust. 2004;181:252-5.
3. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the effectiveness of community pharmacy-based interventions to reduce risk behaviours and risk factors for coronary heart disease. J Public Health. 2003;25(2):144-53.
4. Snella KA, Canales AE, Irons BK, et al. Pharmacy and community based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc. 2006;46(3):370-7.
5. Mangum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community based hypertension and stroke prevention screening projects. J Am Pharm Assoc. 2003;43(1):50-5.
6. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162(10): 1149-55.
7. Tsuyuki RT, Olson KL, Dubyk AM, Schindel TJ, Johnson JA. Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the second study of cardiovascular risk intervention by pharmacist (SCRIP-plus). Am J Med. 2004;116:130-3.
8. Krass I, Hourihan F, Chen T. Health promotion and screening for cardiovascular risk factors in NSW: a community pharmacy model. Health Promot J Aust. 2003; 14(2): 101-7.
9. Doucette WR, Kreling DH, Schommer JC, Gaither CA, Molt DA, Pedersen CA. Evaluation of community pharmacy mix: evidence from the 2004 National Pharmacist Workforce Study. J Am Pharm Assoc. 2006;46:348-55.
10. Bradley F, Elvey R, Ashcroft D, Noyce P. Commissioning services and the new community pharmacy contract: (3) uptake of enhanced services. Pharmaceutical Journal. 2006;277:224-5.
11. Berbatis C, Sunderland VB, Bulsara M, Mills C. Australia's Community Pharmacy Survey: National Pharmacy Database Project, 2002-2003 [database on the Internet]. Canberra (AUST): Statistical Clearing House; Commonwealth of Australia 2004 [cited 2006 Nov 1]. Available from: http://www.nss.gov.au/nss/home.NSF/84c014dd96ddf6cbca257118001dbbee/ d66c47a90eebd9d3ca256b280010fl4f?OpenDocument
12. Berbatis CG, Sunderland VB, Joyce AW, Bulsara M, Mills CR. Characteristics of Australia's community pharmacies: National Pharmacy Database Project. International Journal of Pharmacy Practice. 2007;15:265-71.
13. Krass I. A comparison of clients' experiences of counselling for prescriptions and over-the-counter medications in two types of pharmacies: validation of a research instrument. Journal of Social and Administrative Pharmacy. 1996;13: 206-14.
14. Whitehead P, Atkin P, Krass I, Benrimoj SI. Patient drug information and consumer choice of pharmacy. International Journal of Pharmacy Practice. 1999;7:71-9.
15. Benrimoj SI, Frommer MS. Community pharmacy in Australia. Aust Health Rev. 2004;28(2):238-46.
16. Berbatis C. Point-of-care payments for pharmacies. Australian Pharmacist. 2003;2(5):340.
17. Norris P. The New Zealand Retail Pharmacy Sector. Journal of Social and Administrative Pharmacy. 2003;20(5): 187-93.